The Sir Andrew Witty GSK Scholarships will be funded by GSK and run by the London School of Hygiene & Tropical Medicine 10-year agreement to fund 30 scholars from sub-Saharan Africa on a Master of Science programme London UK – 29 March 2017 – GSK has today announced a new partnership with the London School […]
Groundbreaking UK/US initiative will deliver first data within a year London UK – 23 March 2017 – UK Biobank today announced a major research initiative with GSK and the Regeneron Genetics Center (RGC) to generate genetic sequence data from the 500,000 volunteer participants in the UK Biobank resource. The initiative will enable researchers to gain […]
Presented at ACC and published in Journal of American College of Cardiology, the CardioMEMS™ HF System offers sustained benefits for patients suffering from symptomatic heart failure Heart failure hospitalizations cut nearly in half and an average reduction of $10,500 in comprehensive health care costs six months following implant WASHINGTON, March 19, 2017 /PRNewswire/ — New […]
92.8% procedural success observed in reducing leaky heart valve 80.0% of those treated free from repeat heart failure re-hospitalization 85.9% of patients were discharged to home after two-day average hospital stay WASHINGTON, March 18, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip […]
Results emphasize importance of proper vessel sizing and following current instructions for use for optimal clinical outcomes WASHINGTON, March 18, 2017 — Abbott today announced that data from the ABSORB III U.S. pivotal trial showed that Absorb, Abbott’s first-of-its-kind dissolving stent, had comparable efficacy and safety results to XIENCE, Abbott’s leading metallic drug-eluting stent, between […]
Oral Dydrogesterone has the potential to become new treatment of choice for an estimated 1.5 million women worldwide who undergo IVF treatment each year (1, 2) ABBOTT PARK, Ill., March 8, 2017 /PRNewswire/ — New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million […]
London UK – 01 March 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the closure of an agreement with Aspen (JSE: APN) aligned with GSK’s strategy of simplification through focusing on core therapeutic areas. GSK has divested its anaesthesia portfolio to Aspen (excluding the US and Canada which had been previously divested) for £180m plus […]
Sensor EnabledTM tool complements the EnSite PrecisionTM cardiac mapping system and expands Abbott’s comprehensive advanced cardiac mapping and ablation portfolio ABBOTT PARK, Ill., March 1, 2017 — Abbott today announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility™ Ablation Catheter, Sensor Enabled™ designed to improve the versatility and precision during cardiac ablation procedures […]
London – 19 January 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Abbas Hussain, President, Global Pharmaceuticals has decided to leave the company. He has agreed with GSK that he will leave the company later this year. Abbas joined GSK in 2008 and has held roles of increasing responsibility within the company’s pharmaceutical business. […]
London – 19 January 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Luke Miels has been appointed President, Global Pharmaceuticals, GSK. He will be responsible for a portfolio of medicines and vaccines with annual sales of more than £15 billion and operations in over 100 markets. Luke will report to Emma Walmsley, who is […]